Skip to content
lifestyle.getpetsavvy.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aktis Oncology Inc.
Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress
November 12, 2026
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3
October 7, 2026
Aktis Oncology to Present at Upcoming September Investor Conferences
September 9, 2026
Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026
August 17, 2026